Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts and uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Oragenics ( (OGEN) ) has shared an update.
On January 16, 2025, Oragenics, Inc.’s Board of Directors appointed Ms. Janet Huffman as the Interim Chief Executive Officer, effective immediately. This appointment came with modifications to her employment agreement, including a salary increase to $275,000 and a change in her working location to Sarasota, following the company’s relocation from Tampa. Additionally, she received a discretionary cash bonus of $75,000. On January 15, 2025, Mr. Bruce Cassidy resigned as director to pursue other opportunities, with his resignation unrelated to any disagreements with the company.
More about Oragenics
YTD Price Performance: -17.22%
Average Trading Volume: 892,255
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: $3.75M
Find detailed analytics on OGEN stock on TipRanks’ Stock Analysis page.
